Dosing & Uses
Pompe Disease
Pending FDA approval for use in conjunction with miglustat for treatment of late onset Pompe disease
Next:
Pharmacology
Mechanism of Action
Enzyme replacement therapy; recombinant human acid alpha-glucosidase enzyme with optimized carbohydrate structures to enhance uptake into cells
Used with miglustat, a stabilizer of cipaglucosidase alfa
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
